LCD L39682: MolDX: Molecular Testing for Risk Stratification of Thyroid Nodules — Noridian
Policy LCD-L39682 · Endocrinology
New Molecular Testing LCD for Thyroid Nodules by Noridian.
Code intelligence
Z12.83 reimbursement alerts
Policy changes, MAC LCD updates, and CMS guidance matched to code Z12.83.
Elevated code riskView ICD-10 detail
Signal breakdown
4 shown · 4 total in platform
Risk: Elevated
0
Critical
0%
3
High
75%
1
Routine
25%
0
Low
0%
New this month
—
alerts added in last 30 days
Effective soon
—
no upcoming deadlines
High
LCD L37750: MolDX: Melanoma Risk Stratification Molecular Testing — Noridian
Policy LCD-L37750 · Oncology
New molecular testing guidelines for melanoma risk coming in 2026.
LCD L39589: MolDX: Molecular Biomarker Testing for Risk Stratification of Cutaneous Squamous Cell Carcinoma — Noridian
Policy LCD-L39589 · Dermatology
Update billing practices for cutaneous SCC biomarker testing.
LCD L38153: MolDX: Pigmented Lesion Assay — Noridian
Policy LCD-L38153 · Dermatology
New LCD affects billing for Pigmented Lesion Assay.
Audit documentation
Building an audit file that includes Z12.83?
The Tripwire Audit Pack exports 12 months of Endocrinology policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.
Get the Endocrinology audit pack — $349One-time purchase · not a subscription